How often should vital signs be measured in a patient with AGN?

How often should vital signs be measured in a patient with AGN?

• A. Every hour
• B. Every 4 hours
• C. Once a day
• D. Only when symptoms worsen

Answer: (B)

Vital signs in a patient with Acute Glomerulonephritis (AGN) are typically monitored every four hours to ensure that any changes in the patient’s condition are promptly identified and addressed. This frequency allows healthcare providers to detect fluctuations that could indicate complications such as fluid overload, hypertension, or worsening kidney function, which are common concerns in AGN. Monitoring vital signs at this interval balances the need for vigilance with the practicalities of care, ensuring that the patient is safely managed without overwhelming nursing resources. While more frequent measurements, such as every hour, could be appropriate in a highly critical situation, for stable patients with AGN, every four hours is usually sufficient. Daily measurements or only monitoring when symptoms worsen could lead to missed opportunities for timely interventions that could prevent disease progression or other adverse outcomes.

Vital signs in a patient with Acute Glomerulonephritis (AGN) are typically monitored every four hours to ensure that any changes in the patient’s condition are promptly identified and addressed.

This frequency allows healthcare providers to detect fluctuations that could indicate complications such as fluid overload, hypertension, or worsening kidney function, which are common concerns in AGN. Monitoring vital signs at this interval balances the need for vigilance with the practicalities of care, ensuring that the patient is safely managed without overwhelming nursing resources.

While more frequent measurements, such as every hour, could be appropriate in a highly critical situation, for stable patients with AGN, every four hours is usually sufficient. Daily measurements or only monitoring when symptoms worsen could lead to missed opportunities for timely interventions that could prevent disease progression or other adverse outcomes.